Abstract
Purpose of Review
To synthesize findings from studies of neurocognitive complications in children with type 1 diabetes (T1D) and highlight potential risk and protective factors.
Recent Findings
Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia. Further, diabetic ketoacidosis (DKA) at the time of T1D diagnosis appears to be a particular risk factor for neurocognitive complications, particularly deficits in executive function skills and memory, with differences in cerebral white matter microstructure seen via advanced magnetic resonance imaging methods, and lower scores on measures of attention and memory observed among children who were diagnosed in DKA. Other factors that may influence neurocognitive development include child sleep, caregiver distress, and diabetes device use, presumably due to improved glycemic control.
Summary
We highlight neurocognitive risk and protective factors for children with T1D and priorities for future research in this high-risk population.
Similar content being viewed by others
Data Availability
Not applicable
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Gaudieri PA, Chen R, Greer TF, Holmes CS. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care. 2008;31(9):1892–7.
Naguib JM, Kulinskaya E, Lomax CL, Garralda ME. Neuro-cognitive performance in children with type 1 diabetes--a meta-analysis. J Pediatr Psychol. 2009;34(3):271–82.
Broadley MM, White MJ, Andrew B. A systematic review and meta-analysis of executive function performance in type 1 diabetes mellitus. Psychosomat Med. 2017;79(6):684–96.
Mazaika PK, Weinzimer SA, Mauras N, Buckingham B, White NH, Tsalikian E, et al. Variations in brain volume and growth in young children with type 1 diabetes. Diabetes. 2016;65(2):476–85.
Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, et al. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015;64(5):1770–9.
•• Aye T, Mazaika PK, Mauras N, Marzelli MJ, Shen H, Hershey T, et al. Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care. 2019;42(3):443–9. This study followed children with early onset type 1 diabetes to assess the impact of DKA on cognitive function and brain development over time.
Blasetti A, Chiuri RM, Tocco AM, Giulio CD, Mattei PA, Ballone E, et al. The effect of recurrent severe hypoglycemia on cognitive performance in children with type 1 diabetes:a meta-analysis. J Child Neurol. 2011;26(11):1383–91.
Barnea-Goraly N, Raman M, Mazaika P, Marzelli M, Hershey T, Weinzimer SA, et al. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care. 2014;37(2):332–40.
Silverstein JH, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel LMB, et al. Care of children and adolescents with type 1 diabetes. Diabetes Care. 2005;28:184–212.
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593–603.
Duke DC, Harris MA. Executive function, adherence, and glycemic control in adolescents: a literature review. Curr Diabetes Rep. 2014;14:532.
Wasserman RM, Hilliard ME, Schwartz DD, Anderson BJ. Practical strategies to enhance executive functioning and strengthen diabetes management across the lifespan. Curr Diabetes Rep. 2015;15(8):52.
Perez KM, Patel NJ, Lord JH, Savin KL, Monzon AD, Whittemore R, et al. Executive function in adolescents with type 1 diabetes: relationship to adherence, glycemic control, and psychosocial outcomes. J Pediatr Psychol. 2017;42:636–46.
Hamburger ER, Lyttle M, Compas BE, Jaser SS. Performance-based and questionnaire measures of executive function in adolescents with type 1 diabetes. J Behav Med. 2019;42(6):1041–9.
• Cameron FJ, Northam EA, Ryan CM. The effect of type 1 diabetes on the developing brain. Lancet Child Adolesc Health. 2019;3(6):427–36. This review highlights the link between cognitive function, diabetes management, and glycemic control.
Ryan CM. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes. 2006;7(5):289–97.
Jessup AB, Grimley MB, Meyer E, Passmore GP, Belger A, Hoffman WH, et al. Effects of diabetic ketoacidosis on visual and verbal neurocognitive function in young patients presenting with new-onset type 1 diabetes. J Clin Res Pediatr Endocrinol. 2015;7(3):203–10.
Semenkovich K, Bischoff A, Doty T, Nelson S, Siller AF, Hershey T, et al. Clinical presentation and memory function in youth with type 1 diabetes. Pediatr Diabetes. 2016;17(7):492–9.
He J, Zhu J, Xie Y, Du H, Li S, Li S, et al. Effects of diabetic ketoacidosis on executive function in children with type 1 diabetes: evidence from Wisconsin card sorting test performance. Psychosom Med. 2020;82(4):359–65.
•• Ghetti S, Kuppermann N, Rewers A, Myers SR, Schunk JE, Stoner MJ, et al. Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes. Diabetes Care. 2020;43:2768–75. This study was one of the largest to assess the effects of DKA on cognitive function among children with type 1 diabetes.
Suchy Y, Turner SL, Queen TL, Durracio K, Wiebe DJ, Butner J, et al. The relation of questionnaire and performance-based measures of executive functioning with type 1 diabetes outcomes among late adolescents. Health Psychol. 2016;35(7):661–9.
Berg CA, Wiebe DJ, Suchy Y, Turner SL, Butner J, Munion A, et al. Executive function predicting longitudinal change in type 1 diabetes management during the transition to emerging adulthood. Diabetes Care. 2018;41(11):2281–8.
ABCD Youth Protocol Summary: Baseline. https://abcdstudy.org/wp-content/uploads/2019/12/flyer_protocol_Baseline_new.pdf. Accessed 21 Feb 2021
Horsfield MA, Jones DK. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR in Biomed. 2002;15(7-8):570–7.
Mukherjee P, Berman JI, Chung SW, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. Am J Neuroradiol. 2008;29(4):632–41.
Berman JI, Lanza MR, Blaskey L, Edgar JC, Roberts TP. High angular resolution diffusion imaging probabilistic tractography of the auditory radiation. Am J Neuroradiol. 2013;34(8):1573–8.
Turken A, Whitfield-Gabrieli S, Bammer R, Baldo JV, Dronkers NF, Gabrieli JD. Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage. 2008;42(2):1032–44.
Fields ME, Mirro AE, Guilliams KP, Binkley MM, Gil Diaz L, Tan J, et al. Functional connectivity decreases with metabolic stress in sickle cell disease. Ann Neurol. 2020;88(5):995–1008.
Cato MA, Mauras N, Ambrosino J, Bondurant A, Conrad AL, Kollman C, et al. Cognitive functioning in young children with type 1 diabetes. J Int Neuropsychol. 2014;20(2):238–47.
Perantie DC, Koller JM, Weaver PM, Lugar HM, Black KJ, White NH, et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes. 2011;60(11):3006–14.
Aye T, Barnea-Goraly N, Ambler C, Hoang S, Schleifer K, Park Y, et al. White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study. Diabetes Care. 2012;35(11):2167–73.
Fox LA, Hershey T, Mauras N, Arbelaez AM, Tamborlane WV, Buckingham B, et al. Persistence of abnormalities in white matter in children with type 1 diabetes. Diabetologia. 2018;61(7):1538–47.
Toprak H, Yetis H, Alkan A, Filiz M, Kurtcan S, Aralasmak A, et al. Relationships of DTI findings with neurocognitive dysfunction in children with Type 1 diabetes mellitus. Br J Radiol. 2016;89(1059):20150680.
Song J, Cui S, Chen Y, Ye X, Huang X, Su H, et al. Disrupted regional cerebral blood flow in children with newly-diagnosed type 1 diabetes mellitus: an arterial spin labeling perfusion magnetic resonance imaging study. Front Neurol. 2020;11:572.
Liu K, Song J, Jin J, Huang X, Ye X, Cui S, et al. abnormal functional connectivity density in new-onset type 1 diabetes mellitus children: a resting-state functional magnetic resonance imaging study. Front Psychiatry. 2020;11:284.
Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005;28(3):726–35.
Salvadori E, Brambilla M, Cova I, Pomati S, Pantoni L. Cognitive evaluation in cerebral small vessel disease: towards an evidence-based identification of the reference standards. Part 1. A systematic review and qualitative data synthesis. J Neurol. 2020. https://doi.org/10.1007/s00415-020-10262-2.
Perfect MM, Patel PG, Scott RE, Wheeler MD, Patel C, Griffin K, et al. Sleep, glucose, and functioning in youth with type 1 diabetes. Sleep. 2012;35:81–8.
Donga E, Van Dijk M, Van Dijk JG, Biermasz NR, Lammers GJ, Van Kralingen K, et al. Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care. 2010;33:1573–7.
Stein MA, Mendelsohn J, Obermeyer WH, Amromin J, Benca R. Sleep and behavior problems in school-aged children. Pediatrics. 2001;107:E60.
Jaser SS, Foster NC, Nelson BA, Kittelsrud JM, DiMeglio LA, Quinn M, et al. Sleep in children with type 1 diabetes and their parents in the T1D Exchange. Sleep Med. 2017;39:108–15.
Vriend JL, Davidson FD, Corkum PV, Rusak B, Chambers CT, McLaughlin EN. Manipulating sleep duration alters emotional functioning and cognitive performance in children. J Pediatr Psychol. 2013;38(10):1058–69.
Sadeh A, Gruber R, Raviv A. The effects of sleep restriction and extension on school-age children: what a difference an hour makes. Child Dev. 2003;74:444–55.
Beebe DW. Cognitive, behavioral, and functional consequences of inadequate sleep in children and adolescents. Pediatr Clin North Am. 2011;58:649–65.
Whittemore R, Jaser SS, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012;38:562–79.
Lebel C, Walton M, Letourneau N, Giesbrecht GF, Kaplan BJ, Dewey D. Prepartum and postpartum maternal depressive symptoms are related to children’s brain structure in preschool. Biol Psychiatr. 2016;80(11):859–68.
Liu Y, Kaaya S, Chai J, McCoy D, Surkan P, Black M, et al. Maternal depressive symptoms and early childhood cognitive development: a meta-analysis. Psychol Med. 2017;47(4):680–9.
Van Der Waerden J, Bernard JY, De Agostini M, Saurel-Cubizolles MJ, Peyre H, Heude B, et al. Persistent maternal depressive symptoms trajectories influence children’s IQ: the EDEN mother–child cohort. Depress Anxiety. 2017;34(2):105–17.
Young MJ, Wiebe DJ, Cameron LD. Maternal trait anxiety and diabetes control in adolescents with type 1 diabetes. J Pediatr Psychol. 2007;32(7):733–44.
Driscoll KA, Raymond J, Naranjo D, Patton SR. Fear of hypoglycemia in children and adolescents and their parents with type 1 diabetes. Curr Diabetes Rep. 2016;16(8):77.
Eilander M, Snoek FJ, Rotteveel J, Aanstoot H-J, Bakker-van Waarde WM, Houdijk EC, et al. Parental diabetes behaviors and distress are related to glycemic control in youth with type 1 diabetes: longitudinal data from the DINO study. J Diabetes Res. 2017;2017:1–7.
The Juvenile Diabetes Research Foundation Continous Glucose Monitoring Study Group. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care. 2009;32(11):2047–9.
Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155–63.
Landau Z, Rachmiel M, Pinhas-Hamiel O, Boaz M, Bar-Danyan J, Wainstein R. Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes. Acta Diabetologica. 2014;51:499–503.
Sinisterra M, Hamburger S, Tully C, Hamburger E, Jaser S, Streisand R. Young children with type 1 diabetes: sleep, health-related quality of life, and continuous glucose monitor use. Diabetes Tech Ther. 2020;22:639–42.
Nunley KA, Rosano C, Ryan CM, Jennings JR, Aizenstein HJ, Zgibor JC, et al. Clinically relevant cognitive impairment in middle-aged adults with childhood-onset type 1 diabetes. Diabetes Care. 2015;38(9):1768–76.
Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, et al. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016;6(5):e011144.
Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, et al. Reduced prevalence of diabetes ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011. https://doi.org/10.2337/dc11-1026.
Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatr Diabetes. 2012;13(4):308–13.
Jaser SS, Bergner EM, Hamburger ER, Bhatia S, Lyttle M, Bell GE, et al. Pilot trial of a sleep-promoting intervention for children with type 1 diabetes. J Pediatr Psychol. In press.
Jaser SS, Hamburger ER, Pagoto S, Williams R, Meyn A, Jones AC, et al. Communication and coping intervention for mothers of adolescents with type 1 diabetes: rationale and trial design. Contemp Clin Trials. 2019;85:105844.
Budney A, Lansing AH, Scherer E, Stanger C, Christiano AS, Casella SJ. A web-delivered multicomponent intervention for adolescents with poorly controlled type 1 diabetes: a pilot randomized controlled trial. Ann Behav Med. 2018;52(12):1010–22.
Code Availability
Not applicable
Funding
NIH/NIDDK U34-DK123895
Author information
Authors and Affiliations
Contributions
SSJ researched and wrote the paper. LJ researched and wrote the paper.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Psychosocial Aspects
Rights and permissions
About this article
Cite this article
Jaser, S.S., Jordan, L.C. Brain Health in Children with Type 1 Diabetes: Risk and Protective Factors. Curr Diab Rep 21, 12 (2021). https://doi.org/10.1007/s11892-021-01380-w
Accepted:
Published:
DOI: https://doi.org/10.1007/s11892-021-01380-w